Other Assets, Noncurrent of REGENXBIO Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
REGENXBIO Inc. quarterly Other Assets, Noncurrent in USD history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • REGENXBIO Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $4,268,000, a 1.5% decline year-over-year.
Source SEC data
View on sec.gov
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

REGENXBIO Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,268,000 -$64,000 -1.5% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,879,000 -$1,067,000 -36% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $2,987,000 -$1,230,000 -29% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $4,000,000 -$807,000 -17% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $4,332,000 -$337,000 -7.2% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $2,946,000 -$887,000 -23% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $4,217,000 -$4,073,000 -49% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $4,807,000 -$1,590,000 -25% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $4,669,000 -$3,681,000 -44% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $3,833,000 -$2,072,000 -35% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $8,290,000 -$239,000 -2.8% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $6,397,000 -$31,000 -0.48% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $8,350,000 -$208,000 -2.4% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $5,905,000 -$1,787,000 -23% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $8,529,000 -$539,000 -5.9% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $6,428,000 +$1,149,000 +22% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $8,558,000 +$4,198,000 +96% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $7,692,000 +$3,369,000 +78% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $9,068,000 +$6,218,000 +218% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $5,279,000 +$724,000 +16% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $4,360,000 +$349,000 +8.7% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $4,323,000 +$1,112,000 +35% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $2,850,000 +$595,000 +26% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $4,555,000 +$2,240,000 +97% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $4,011,000 +$2,361,000 +143% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $3,211,000 +$1,697,000 +112% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $2,255,000 +$1,372,000 +155% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $2,315,000 +$1,453,000 +169% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 $1,650,000 +$814,000 +97% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $1,514,000 +$1,121,000 +285% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $883,000 +$586,000 +197% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 $862,000 +$462,000 +116% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 $836,000 +$597,000 +250% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $393,000 +$127,000 +48% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $297,000 +$74,000 +33% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $400,000 +$232,000 +138% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q3 2016 $239,000 +$111,000 +87% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $266,000 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $223,000 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 $168,000 31 Dec 2015 10-K 07 Mar 2017 2016 FY
Q3 2015 $128,000 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.